SAVIMS

Other scientific evidence

COVID-19, Epidemiological surveillance, Other scientific evidence, Other viral illnesses, Resource Type, Statistical evidence, Viral illnesses

COVID-19 and Influenza Surveillance Insights (UKHSA – 2022)

Reference: UK Health Security Agency. (2022). Weekly national influenza and COVID-19 surveillance report: week 5 report (up to week 4 data). Summary: The UK Health Security Agency’s report for Week 5 of 2022 highlights a decrease in COVID-19 activity in England during Week 4, with reductions in case rates across various demographics. While positive rates […]

Covid-19 vaccines, Other scientific evidence, Resource Type, Treatment, Vaccine safety & adverse events, Vaccines

Vaccine Injury Treatment Guide Elizabeth Lee Vliet

Reference: Vliet, E. L. (2022). Vaccine injury treatment guide: Your road map to recovery. Truth for Health Foundation. Retrieved from www.TruthForHealth.org Summary: The “Vaccine Injury Treatment Guide” provides a comprehensive resource for individuals experiencing adverse effects from COVID-19 vaccines. Authored by Dr Elizabeth Lee Vliet and her team, it is based on peer-reviewed research and

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Transmission Dynamics of SARS-CoV-2 Omicron Variant in Danish Households

Reference: Lyngse, F. P., Mortensen, L. H., Denwood, M. J., Christiansen, L. E., Møller, C. H., Skov, R. L., … & Krause, T. G. (2021). SARS-CoV-2 Omicron VOC transmission in Danish households. medRxiv. https://doi.org/10.1101/2021.12.27.21268278 Summary: This study investigates the transmission of the Omicron variant of SARS-CoV-2 within Danish households, comparing it to the Delta variant.

COVID-19, Covid-19 vaccines, Other scientific evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Safety Analysis of Ad26.COV2.S Vaccine Among South African Healthcare Workers

Reference: Takuva, S., Takalani, A., Seocharan, I., Yende-Zuma, N., Reddy, T., Engelbrecht, I., Faesen, M., Khutlo, K., Whyte, C., Bailey, V., Trivella, V., Peter, J., Opie, J., Louw, V., Rowji, P., Jacobson, B., Groenewald, P., Dorrington, R. E., Laubscher, R., Bradshaw, D., Moultrie, H., Fairall, L., Sanne, I., Gail-Bekker, L., Gray, G., Gogar, A., Garrett,

COVID-19, Covid-19 vaccines, Excess deaths, Other scientific evidence, Statistical evidence, Vaccines, Viral illnesses

Evaluating Covid-19 Vaccination Effects on Mortality in New Zealand

Reference: Hatchard, G. (2021, December 17). Relationship between Covid-19 vaccination and all cause mortality. Hatchard Report. https://hatchardreport.com/relationship-between-covid-19-vaccination-and-all-cause-mortality/ Summary: The article by Guy Hatchard investigates the correlation between mRNA Covid-19 vaccinations and all-cause mortality rates in New Zealand, particularly among individuals aged 60 and over. The analysis, facilitated by New Zealand’s unique border controls, allows for

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Excess deaths, Other scientific evidence, Resource Type, Statistical evidence, Vaccine safety & adverse events, Vaccines, Viral illnesses

Analysis of Mis-categorisation in Covid-19 Mortality Data

Reference: Neil, M., Fenton, N., Smalley, J., Craig, C., Guetzkow, J., McLachlan, S., Engler, J., & Rose, J. (2021). Latest statistics on England mortality data suggest systematic mis-categorisation of vaccine status and uncertain effectiveness of Covid-19 vaccination. ResearchGate. https://doi.org/10.13140/RG.2.2.14176.20483 Summary: This article scrutinises England’s Covid-19 mortality data, revealing potential systematic mis-categorisation of vaccination status. While

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Long-term Persistence of SARS-CoV-2 Spike Protein: Implications for Vaccination

Reference: Palmer, M., & Bhakdi, S. (2021). Long-term persistence of the SARS-CoV-2 spike protein: Evidence and implications. doctors4covidethics.org. Summary: The article by Palmer and Bhakdi examines a study by Bansal et al. that identified the presence of SARS-CoV-2 spike protein in exosomes for up to four months post-vaccination with the Pfizer mRNA vaccine. This prolonged

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Long-term Persistence of SARS-CoV-2 Spike Protein: Implications for Health

Reference: Palmer, M., & Bhakdi, S. (2021). Long-term persistence of the SARS-CoV-2 spike protein: Evidence and implications. doctors4covidethics.org. Summary: The article by Palmer and Bhakdi discusses a study by Bansal et al. that reveals the prolonged presence of the SARS-CoV-2 spike protein in individuals vaccinated with the Pfizer mRNA vaccine. It highlights that the spike

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccines, Viral illnesses

Understanding RRR and ARR in Vaccine Trials

Reference: Iriarte, I., & Phoenix, S. (2021). Understanding relative risk reduction (RRR) and absolute risk reduction (ARR) in vaccine trials. PANDA. https://www.pandata.org/understanding-relative-risk-reduction-and-absolute-risk-reduction-in-vaccine-trials/ Summary: The article discusses the critical distinctions between Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR) in the context of vaccine trials, particularly those for COVID-19. RRR compares the efficacy of one

COVID-19, Covid-19 vaccines, Other scientific evidence, Resource Type, Vaccine safety & adverse events, Vaccines, Viral illnesses

Detection of Graphene in COVID-19 Vaccines

Reference: Campra, P. (2021). Detection of graphene in COVID-19 vaccines by micro-Raman spectroscopy. Technical Report. Almeria, Spain: Universidad de Almería. Summary: This technical report by Professor Pablo Campra investigates the presence of graphene in various COVID-19 vaccine samples using a technique called micro-Raman spectroscopy. The study screened seven vials from four different vaccine brands, identifying

Scroll to Top